Keith Cummings

CFO

Board Member

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

Affiliation history

Recorded current and former roles; source labels appear when available.

Recorded roles and earnings-call appearances connecting this person to public companies.

PLRX

Current role

CFO, Board Member

2018-01-01–present

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2025	Pliant Therapeutics, Inc. (PLRX)	M.D., M.B.A. Chief Financial Officer	$503,876	$201,550	$631,081	$946,055	$100,775	$14,000	$2,397,337
2024	Pliant Therapeutics, Inc. (PLRX)	M.D., M.B.A. Chief Financial Officer	$484,496	—	$963,560	$1,423,240	$213,178	$15,400	$3,099,874
2023	Pliant Therapeutics, Inc. (PLRX)	M.D., M.B.A. Chief Financial Officer	$452,800	—	$1,871,100	$1,883,664	$217,344	$14,000	$4,438,908
2022	Pliant Therapeutics, Inc. (PLRX)	M.D., M.B.A. Chief Financial Officer	$427,200	—	$1,810,400	$970,610	$222,144	$13,000	$3,443,354
2021	Pliant Therapeutics, Inc. (PLRX)	M.D., MBA Chief Financial Officer	$401,700	—	—	$1,277,627	$192,816	$11,600	$1,883,743

No earnings-call appearances or filed executive changes recorded yet.